Caprock Group’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$146K	Buy	10,497 +158	+2%	+$2.52K	﹤0.01%	1067
2025 Q4	$168K	Sell	10,339 -568	-5%	-$9.27K	﹤0.01%	1132
2025 Q3	$144K	Buy	+10,907	New	+$133K	﹤0.01%	1087
2025 Q1	$81.3K	Buy	10,944 +529	+5%	+$4.07K	﹤0.01%	1043
2024 Q4	$62.4K	Sell	10,415 -2,500	-19%	-$13.8K	﹤0.01%	974
2024 Q3	$66.1K	Buy	12,915 +357	+3%	+$1.55K	﹤0.01%	880
2024 Q2	$45.5K	Sell	12,558 -12,516	-50%	-$39.7K	﹤0.01%	843
2024 Q1	$80.5K	Sell	25,074 -28	-0.1%	-$108	﹤0.01%	704
2023 Q4	$123K	Sell	25,102 -17	-0.1%	-$78	0.01%	669
2023 Q3	$137K	Sell	25,119 -300	-1%	-$1.98K	0.01%	627
2023 Q2	$171K	Hold	25,419	–	–	0.01%	623
2023 Q1	$224K	Hold	25,419	–	–	0.02%	569
2022 Q4	$194K	Sell	25,419 -1,919	-7%	-$14.9K	0.02%	511
2022 Q3	$195K	Sell	27,338 -414	-1%	-$3.9K	0.02%	523
2022 Q2	$225K	Sell	27,752 -4,586	-14%	-$40.3K	0.02%	467
2022 Q1	$449K	Sell	32,338 -3,000	-8%	-$47.2K	0.04%	318
2021 Q4	$992K	Sell	35,338 -10,700	-23%	-$328K	0.08%	176
2021 Q3	$1.56M	Hold	46,038	–	–	0.14%	103
2021 Q2	$1.88M	Sell	46,038 -3,000	-6%	-$117K	0.17%	93
2021 Q1	$1.97M	Buy	49,038 +18,758	+62%	+$1.02M	0.22%	76
2020 Q4	$1.79M	Sell	30,280 -10,430	-26%	-$538K	0.2%	81
2020 Q3	$1.98M	Sell	40,710 -7,500	-16%	-$315K	0.27%	66
2020 Q2	$2.33M	Hold	48,210	–	–	0.35%	52
2020 Q1	$1.34M	Buy	48,210 +40,672	+540%	+$1.13M	0.25%	77
2019 Q4	$226K	Buy	7,538 +38	+0.5%	+$1.09K	0.04%	302
2019 Q3	$232K	Buy	+7,500	New	+$306K	0.05%	287